Jun 1
Eli Lilly and Company Retevmo shows major reduction in cancer recurrence risk trial
Eli Lilly's Retevmo cut cancer recurrence or death risk by 83% in the Phase 3 LIBRETTO-432 trial of 151 NSCLC patients. 24-month EFS hit 92%
Loading...
seen from Malaysia
seen from United States
seen from China
seen from United States
seen from United States
seen from United States
seen from Canada
seen from United States
seen from Malaysia
seen from United States
seen from China
seen from China
seen from United States
seen from United States
seen from Australia
seen from Ecuador
seen from Canada
seen from Russia
seen from United States
seen from United States
Eli Lilly and Company Retevmo shows major reduction in cancer recurrence risk trial
Eli Lilly's Retevmo cut cancer recurrence or death risk by 83% in the Phase 3 LIBRETTO-432 trial of 151 NSCLC patients. 24-month EFS hit 92%
Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming